Till startsida
University of Gothenburg
To content Read more about how we use cookies on gu.se

Ethical approval for new Phase I study

News: Jan 13, 2014

The Regional Ethical Review Board in Göteborg approved our forthcoming Phase I study with i.p. 211At-Rebmab200 (a humanized whole IgG version of the MX35 antibody) on 2013-12-19. We now continue approaching the Swedish Medical Products Agency in Uppsala and will meet with them on 14th of February


Page Manager: Emma Aneheim|Last update: 4/8/2011

The University of Gothenburg uses cookies to provide you with the best possible user experience. By continuing on this website, you approve of our use of cookies.  What are cookies?